Bayer completes takeover of Chinese OTC drug-maker Dihon for €470m – Pharmaceutical Business Review

“Germany’s Bayer has completed acquisition of China-based provider of over-the-counter (OTC) and herbal traditional Chinese medicine (TCM) products, Dihon Pharmaceutical Group, for CNY3.6bn (€470m).”